At Partners4Access, we believe patients with rare diseases deserve the right to access the most appropriate treatment. Our vision is ensuring fair access for all key stakeholders. By that, we mean fair access to drugs for rare disease patients, fair value for those that fund treatments, access to the smartest clinical option for the disease expert and a fair re-turn on investment for the orphan drug manufacturer. We work with our biotechnology clients in partnership, to think differently across 5 best practices, and smartly secure access for orphan drugs.
Company Details
- Employees
- 22
- Founded
- -
- Address
- 70 Saint Mary Axe, London,england Ec3a 8be,united Kingdom
- Industry
- Business Consulting And Services
- NAICS
-
Management, Scientific, and Technical Consulting ServicesManagement Consulting ServicesOther Scientific and Technical Consulting ServicesOther Management Consulting Services
- Website
- partners4access.com
- Keywords
- Market Access, Orphan Drugs, Pricing & Reimbursement, Rare Disease, Gene Therapy, Specialists, Research, Global Consultancy, Experts, Orphan Drug Solutions, Partnership, Full Suite of Access Activities, Cell Therapy, ATMP, Global Experts, Patient Access.
- HQ
- London, England
Partners4access Questions
Partners4Access's website is partners4access.com
Partners4Access's LinkedIn profile is https://uk.linkedin.com/company/partners4access
Partners4Access has
22 employees.
View email and phone details for 22
employees at Partners4Access.
Partners4Access's industry is
Business Consulting and Services
Partners4Access's top competitors are
Petauri Evidence,
Inbeeo,
Access Infinity,
Global Pricing Innovations (Gpi),
Decisive Consulting Ltd,
Dolon Ltd,
Cogentia Healthcare Consulting,
Executive Insight, Healthcare Consultants,
Lightning Health,
Remap Consulting.
Partners4Access's categories are Business Consulting and Services
Partners4Access's founding year is 2015
